Mark Giddarie

Sanofi must pay up to $109M for Hyalgan kickbacks

Drugmakers Sanofi-Aventis U.S. Inc. and Sanofi-Aventis U.S. LCC will pay up to $109 million in a settlement over an alleged scheme to provide doctors with free units of its knee-injection drug Hyalgan in return for purchase of the treatment.

Don't miss any McKnight's news

Featured Articles